false
--12-31
0001836875
0001836875
2026-09-10
2026-09-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September
10, 2026
|
NUVVE HOLDING CORP. |
| (Exact Name of Registrant as Specified in Charter) |
| Delaware |
|
001-40296 |
|
86-1617000 |
|
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2488 Historic Decatur Road, Ste 230
San Diego, California |
|
92106 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (619)
456-5161
|
(Former Name or Former Address, if Changed Since
Last Report) |
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading symbols |
|
registered |
| Common Stock, Par Value $0.0001 Per Share |
|
NVVE |
|
OTCQB Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry Into a Material Definitive Agreement.
Securities Purchase Agreement
On September 10, 2026, Nuvve Holding Corp. (the
“Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with FirstFire Global Opportunities
Fund, LLC (“Buyer”), pursuant to which the Company issued and sold to the Buyer a convertible promissory note in the principal
amount of $280,000 (the “Note”). The Note was issued with an original issue discount of $30,000, resulting in a purchase price
of $250,000.
The Note bears interest at a rate of 12% per annum
and matures on September 10, 2027. Commencing on the six-month anniversary of the issuance date, the Buyer may convert all or any portion
of the outstanding principal amount and accrued interest under the Note into shares of the Company’s common stock, par value $0.0001
per share (the “Common Stock”) at a conversion price equal to the lesser of: (i) $1.40 per share, or (ii) 85% of the lowest
trading price of the Common Stock during the ten trading days immediately preceding the applicable conversion date. The Buyer’s
ability to convert the Note is subject to a beneficial ownership limitation of 4.99%. The Note contains customary events of default and
related remedies, including an increase in the interest rate and the conversion discount upon the occurrence of an event of default. The
shares issuable upon the conversion of the Note are subject to certain piggyback registration rights.
In connection with the Purchase Agreement and
the Note, the Company delivered irrevocable instructions to its transfer agent to reserve shares of the Company’s common stock for
issuance upon conversion of the Note (the “Irrevocable Transfer Agent Instructions”).
The foregoing descriptions of the Purchase Agreement,
the Note and the Irrevocable Transfer Agent Instructions are not complete and are qualified in their entirety by reference to the full
text of the Purchase Agreement, the Note and the Irrevocable Transfer Agent Instructions, copies of which are filed as Exhibits 10.1,
4.1 and 99.1 hereto, respectively.
Exchange Agreement
On September 10, 2026, the Company entered into
a securities exchange and amendment agreement (the “Exchange Agreement”) with the holders (the “Holders”) of an
aggregate of 2,238.655 shares (the “Existing Series A Shares”) of the Company’s Series A Preferred Stock, par value
$0.0001 per share (the “Series A Preferred Stock”), representing all of the Company’s outstanding Series A Preferred
Stock. Pursuant to the Exchange Agreement, the Holders agreed to exchange their Existing Series A Shares for an aggregate of 2,238.655
shares of a newly designated Series C Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”)
and stated value of $1,000 per share (the “Stated Value”), in reliance on the exemption from registration provided by Section
3(a)(9) of the Securities Act of 1933, as amended (the “Securities Act”) (such transaction, the “Exchange”).
As previously disclosed, the Company entered into
a registration rights agreement, dated November 14, 2025 (the “Registration Rights Agreement”), with the Holders, pursuant
to which the Company agreed to certain registration rights with regards to the shares of Common Stock underlying the Existing Series A
Shares. Pursuant to the Exchange Agreement, the Registration Rights Agreement shall be amended to provide that the shares of Common Stock
issuable upon the conversion of any shares of Series C Preferred Stock shall be subject to the registration rights set forth in the Registration
Rights Agreement.
The foregoing description of the Exchange Agreement
is not complete and is qualified in its entirety by reference to the full text of the Exchange Agreement, a copy of which is filed as
Exhibit 10.2 hereto.
Item 2.03. Creation of a Direct Financial Obligation
or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth in Item 1.01 of this
Current Report on Form 8-K is incorporated by reference into this Item 2.03.
Item 3.02. Unregistered Sales of Equity Securities.
The disclosure required by this Item and included
in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
The Note and issuance of any shares of Common
Stock upon the conversion thereof will be issued in reliance on the exemption from securities registration under Section 4(a)(2) of the
Securities Act and Rule 506(b) under the Securities Act.
The issuance of the Series C Preferred Stock and
any shares of Common Stock issuable upon the conversion thereof shall be issued in reliance on Section 3(a)(9) of the Securities Act and
under Section 4(a)(2) and Rule 506(b) of the Securities Act.
Item 3.03. Material Modification to Rights of Security Holders.
To the extent required by Item 3.03 of Form 8-K,
the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year.
On September 15, 2026, in connection with the
Exchange Agreement, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred
Stock (the “Certificate of Designation”) with the Secretary of State of Delaware. The Certificate of Designation designates
3,000 shares of the Company’s authorized preferred stock, par value $0.0001 per share, as Series C Preferred Stock and sets forth
the preferences, rights and limitations of the Series C Preferred Stock. The Certificate of Designation became effective upon filing.
Conversion. At any time and from time to
time, a holder of shares of Series C Preferred Stock may, at its option, convert shares of Series C Preferred Stock into a number of shares
of Common Stock, as is determined by (i) multiplying (x) the number of shares of Series C Preferred Stock to be converted by (y) the Stated
Value thereof, and then (ii) dividing the result by the conversion price of $1.40 per share (the “Conversion Price”), subject
to certain conditions. The Conversion Price is subject to full ratchet antidilution protection and certain exceptions upon any subsequent
transaction at a price lower than the Conversion Price then in effect and standard adjustments in the event of stock dividends, stock
splits, combinations or similar events.
Dividends. Holders of the Series C Preferred
Stock shall be entitled to receive cumulative dividends at the rate per share of 8% per annum, payable quarterly. Such dividends shall
be payable, at the election of the Holder, in cash, shares of Common Stock, or any combination of cash and shares of Common Stock.
Voting. Except as otherwise required by
law, the Series C Preferred Stock shall have no voting rights.
Liquidation. In the event of any voluntary
or involuntary liquidation, dissolution or winding-up of the Company (a “Liquidation”), the holders of Series C Preferred
Stock will be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value of
each share of Series C Preferred Stock, plus any other fees or liquidated damages then due and owing thereon, before any distribution
or payment shall be made to the holders of any securities junior to the Series C Preferred Stock.
Ranking. The Series C Preferred Stock ranks
senior to all other shares of capital stock of the Company and any other class or series of preferred stock or other capital stock of
the Company created after the effectiveness of the Certificate of Designation as to payment of dividends, distributions and payments upon
the liquidation, dissolution and winding up of the Company. The Company shall not create a class or series of capital stock that is senior
in rank or pari passu to the Series C Preferred Stock without the consent of the holders of a majority of the Series C Preferred Stock.
The foregoing description of the terms of the
Certificate of Designation is not intended to be complete and is qualified in its entirety by reference to the full text of the Certificate
of Designation, which is filed herewith as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit
No. |
|
Description |
| 3.1 |
|
Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock |
| 4.1 |
|
Promissory Note, dated September 10, 2026 |
| 10.1* |
|
Securities Purchase Agreement, dated September 10, 2026, between Nuvve Holding Corp. and FirstFire Global Opportunities Fund, LLC |
| 10.2* |
|
Securities Exchange and Amendment Agreement, dated September 10, 2026, between Nuvve Holding Corp. and the holders named therein |
| 99.1 |
|
Irrevocable Instruction Letter to Transfer Agent, dated September 10, 2026 |
| 104 |
|
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |
| * | Certain of the exhibits and schedules to this exhibit have
been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish supplementally a copy of all omitted exhibits
and schedules to the SEC upon its request. |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: September 16, 2026
| |
NUVVE HOLDING CORP. |
| |
|
| |
By: |
/s/ Gregory Poilasne |
| |
|
Gregory Poilasne |
| |
|
Chief Executive Officer |
Exhibit 99.1
NUVVE HOLDING CORP.
September 10, 2026
Continental Stock Transfer & Trust Company
1 State Street, Floor 30
New York, NY 10004
Ladies and Gentlemen:
NUVVE HOLDING CORP., a Delaware
corporation (the “Company”) and FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC, a Delaware limited liability company (the “Investor”),
have entered into a securities purchase agreement on or around September 10, 2026 (the “Agreement”), pursuant to which the
Company issued that certain promissory note in the original principal amount of $280,000.00 (the “Note”).
You are hereby irrevocably
authorized and instructed to reserve a sufficient number of shares of common stock, par value $0.0001 per share (“Common Stock”)
of the Company (initially, 5,000,000 shares) for issuance upon full conversion of the Note in accordance with the terms thereof. The amount
of shares so reserved may be increased, from time to time, only upon the written instructions of the Company.
The ability to convert the
Note in a timely manner is a material obligation of the Company pursuant to the Note. Provided that Continental Stock Transfer & Trust
Company (the “Transfer Agent”) is acting as transfer agent at the time, your firm is hereby irrevocably authorized and instructed
to within two (2) Trading days issue shares of Common Stock of the Company to the Investor upon your receipt from the Investor (provided,
however, that the Investor must concurrently provide the following items to the Company as well) of: (i) a notice of conversion under
the Note (“Conversion Notice”) executed by the Investor, (ii) an opinion of the Company's counsel or counsel of the Investor,
confirming that the shares may be issued upon conversion of the Note without any transfer restrictions pursuant to an effective resale
registration statement or pursuant to the exemption provided by Rule 144 (or any other available exemption) under the Securities Act of
1933. as amended (the “Securities Act”), and (iii) copies of all supporting prospectus or supporting documentation (a seller's
representation letter and a broker's representation letter if the shares have been held less than twelve months). Such shares should be
issued at the option of the Investor as specified in the Conversion Notice and/or Exercise Notice either (i) electronically by crediting
the account of a Prime Broker with the Depository Trust Company through its Deposit Withdrawal at Custodian (“DWAC”) system
provided the Investor causes its broker or bank to initiate a DWAC deposit or (ii) in certificated form without any restrictive legend
which would restrict the transfer of the shares, provided however that if such shares are not able to be sold under Rule 144 or any other
exemption under the Securities Act and you have received an opinion from the Company's or Investor's counsel that the issuance of the
shares is exempt from registration under the Securities Act and when issued the shares will be fully paid and non-assessable, then the
issued certificates for such shares shall bear the following restrictive legend:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT OR AN OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE
CUSTOMARY FOR OPINIONS OF COUNSEL IN COMPARABLE TRANSACTIONS. THAT REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 UNDER
SAID ACT OR OTHER APPLICABLE EXEMPTION.
Except with respect to issuances
pursuant to conversions under the Note as provided in this instruction letter, the shares shall remain in the created reserve with the
Transfer Agent until the Investor and an authorized officer of the Company provides joint written instructions to the Transfer Agent that
the shares or any part of them shall be taken out of the reserve and shall no longer be subject to the terms of these instructions.
The Company hereby authorizes
you to disclose to the Investor, after the Investor's request from time to time, the number of shares authorized and issued and outstanding,
the reserve balance, and the cost basis of any issuance of Common Stock made to the Investor.
The Company shall indemnify
you and your officers, directors, principals, partners, agents and representatives, and hold each of them harmless from and against any
and all loss, liability, damage, claim or expense (including the reasonable fees and disbursements of its attorneys) incurred by or asserted
against you or any of them arising out of or in connection with the instructions set forth herein. the performance of your duties hereunder
and otherwise in respect hereof, including the costs and expenses of defending yourself or themselves against any claim or liability including
any claim which may be made or asserted by the Company, except that the Company shall not be liable hereunder as to matters in respect
of which it is determined that you have acted with gross negligence or in bad faith. You shall have no liability to the Company and the
Investor in respect of this if such action was taken or omitted to be taken in good faith, and you shall be entitled to rely in this regard
and without liability on the advice of counsel, including counsel selected by you.
The Board of Directors of
the Company has approved these irrevocable instructions and does hereby extend the Company's irrevocable agreement to indemnify your firm
for all loss, liability or expense in carrying out the authority and direction herein contained on the terms herein set forth.
The Company agrees that in
the event that you resign as the Company's transfer agent, the Company shall engage a suitable replacement transfer agent that will agree
to serve as transfer agent for the Company within five (5) business days. The Company acknowledges that we will have the right to complete
any issuance, conversion request, or exercise request received in good order prior to our resignation. It is also understood that you
are permitted to resign without any stipulated conditions.
The Investor is intended to
be and is a beneficiary hereof and no amendment or modification to the instructions set forth herein may be made without the consent of
the Investor.
Notwithstanding any other
provision hereof, the Company and the Investor understand that you shall not be required to perform any issuance of the shares if (a)
such an issuance or transfer of shares is in violation of any state or federal securities laws or regulations or (b) the issuance of the
shares is prohibited or stopped as required or directed by a court order from a court of competent jurisdiction. Additionally, Company
and Investor understand that you shall not be required to perform any issuance of the shares if Company is in default of its payment obligations
under its agreement with you.
| Very truly yours, |
|
| |
|
|
| NUVVE HOLDING CORP. |
|
| |
|
|
| By: |
/s/ Gregory Poilasne |
|
| Name: |
Gregory Poilasne |
|
| Title: |
Chief Executive Officer |
|
| |
|
|
| Acknowledged and Agreed: |
|
| |
|
|
| CONTINENTAL STOCK TRANSFER & TRUST COMPANY |
| |
|
|
| By: |
/s/ Ana Gois |
|
| Name: |
Ana Gois |
|
| Title: |
Vice President |
|
| |
|
|
| Acknowledged and Agreed: |
|
| |
|
|
| FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC |
| |
|
|
| By: |
FirstFire Capital Management LLC, its manager |
|
| |
|
|
| By: |
/s/ Eli Fireman |
|
| Name: |
Eli Fireman |
|